Market Overview
The Antibody Drug Conjugate Market is expanding its therapeutic footprint beyond traditional oncology applications into autoimmune diseases, infectious diseases, and neurological disorders. While cancer treatment remains the dominant application, the unique mechanism of ADCs—delivering potent therapeutic agents directly to target cells—offers significant...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek